NCT05615311View on ClinicalTrials.gov

Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

March 16, 2023

Primary Completion Date

October 17, 2024

Study Completion Date

May 31, 2026

Conditions
Prematurity; Extreme
Interventions
DIETARY_SUPPLEMENT

Vitamin D supplementation

Study participants assigned to the intervention group will receive 800 IU/ day of vitamin D plus 200-300 IU/day of vitamin D from parenteral and enteral sources during the first 2 weeks after birth.

OTHER

No additional vitamin D supplementation

Study participants assigned to the control group will receive 200-300 IU/ day of vitamin D from parenteral and enteral sources during the first 2 weeks after birth.

Trial Locations (1)

35233

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER